Latest return on equity
Recursion Pharmaceuticals Return on equity
Recursion Pharmaceuticals (RXRX) return on equity with its verified observation…
Direct answer
Recursion Pharmaceuticals's return on equity is -56.58%.
The verified market snapshot reports -56.58%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 26, 2026.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -56.58%
Explore related company data
View Recursion Pharmaceuticals's market capitalizationView Recursion Pharmaceuticals's price-to-book ratioView Recursion Pharmaceuticals's 52-week price rangeView Recursion Pharmaceuticals's revenue growthView Recursion Pharmaceuticals's profit marginView Recursion Pharmaceuticals's debt-to-equity ratioView all Recursion Pharmaceuticals key metricsReturn to Recursion Pharmaceuticals profile